Methamphetamine-induced psychosis: Clinical features, treatment modalities and outcomes
Objective: To investigate the clinical features, prescribing patterns and outcomes of psychiatric inpatients admitted with methamphetamine-induced psychosis. Method: A cross-sectional, descriptive pilot study was conducted between March 2014 and August 2014 at three South African Mental Health Care...
Hoofdauteurs: | , , , , |
---|---|
Formaat: | Artikel |
Taal: | English |
Gepubliceerd in: |
AOSIS
2016-09-01
|
Reeks: | South African Journal of Psychiatry |
Onderwerpen: | |
Online toegang: | http://www.sajp.org.za/index.php/sajp/article/view/980 |
_version_ | 1828531139616178176 |
---|---|
author | Eileen Thomas Helena Lategan Chris Verster Martin Kidd Lize Weich |
author_facet | Eileen Thomas Helena Lategan Chris Verster Martin Kidd Lize Weich |
author_sort | Eileen Thomas |
collection | DOAJ |
description | Objective: To investigate the clinical features, prescribing patterns and outcomes of psychiatric inpatients admitted with methamphetamine-induced psychosis.
Method: A cross-sectional, descriptive pilot study was conducted between March 2014 and August 2014 at three South African Mental Health Care Act designated hospitals prior to admission to a psychiatric hospital. Patients with methamphetamine-related psychotic symptoms according to the DSM-5 criteria were eligible. Structured face-to-face interviews were conducted and the Brief Psychiatric Rating Scale was employed as a measure of current
psychopathology.
Results: Fifty-six participants were included. Positive psychotic symptoms (e.g. hallucinations) were more prominent than negative symptoms (e.g. affective blunting). Almost half the participants (43%) had previous episodes of methamphetamine-induced psychosis. Within this group, all had defaulted on the prescribed treatment prior to admission. Only 29% of the participants had received prior formal substance-use rehabilitation as treatment for their disorder. High rates of comorbid cannabis and alcohol use (51%) were recorded. Most of the participants required transfer to specialist psychiatric hospitals. The amounts of methamphetamine used were not a predictor of the persistence of psychosis; however, the pattern of use was.
Conclusion: Clinical features correspond with other international findings. The currently employed model of sequential, non-integrated psychiatric and substance use treatment in this setting appears ineffective. |
first_indexed | 2024-12-11T22:33:11Z |
format | Article |
id | doaj.art-de0ef6f0700142529e510fce3b901b0f |
institution | Directory Open Access Journal |
issn | 1608-9685 2078-6786 |
language | English |
last_indexed | 2024-12-11T22:33:11Z |
publishDate | 2016-09-01 |
publisher | AOSIS |
record_format | Article |
series | South African Journal of Psychiatry |
spelling | doaj.art-de0ef6f0700142529e510fce3b901b0f2022-12-22T00:48:03ZengAOSISSouth African Journal of Psychiatry1608-96852078-67862016-09-01221e1e610.4102/sajpsychiatry.v22i1.980347Methamphetamine-induced psychosis: Clinical features, treatment modalities and outcomesEileen Thomas0Helena Lategan1Chris Verster2Martin Kidd3Lize Weich4Department of Psychiatry, Stellenbosch UniversityDepartment of Psychiatry, Stellenbosch UniversityDepartment of Psychiatry, Stellenbosch UniversityCentre for Statistical Consultation, Stellenbosch UniversityDepartment of Psychiatry, Stellenbosch UniversityObjective: To investigate the clinical features, prescribing patterns and outcomes of psychiatric inpatients admitted with methamphetamine-induced psychosis. Method: A cross-sectional, descriptive pilot study was conducted between March 2014 and August 2014 at three South African Mental Health Care Act designated hospitals prior to admission to a psychiatric hospital. Patients with methamphetamine-related psychotic symptoms according to the DSM-5 criteria were eligible. Structured face-to-face interviews were conducted and the Brief Psychiatric Rating Scale was employed as a measure of current psychopathology. Results: Fifty-six participants were included. Positive psychotic symptoms (e.g. hallucinations) were more prominent than negative symptoms (e.g. affective blunting). Almost half the participants (43%) had previous episodes of methamphetamine-induced psychosis. Within this group, all had defaulted on the prescribed treatment prior to admission. Only 29% of the participants had received prior formal substance-use rehabilitation as treatment for their disorder. High rates of comorbid cannabis and alcohol use (51%) were recorded. Most of the participants required transfer to specialist psychiatric hospitals. The amounts of methamphetamine used were not a predictor of the persistence of psychosis; however, the pattern of use was. Conclusion: Clinical features correspond with other international findings. The currently employed model of sequential, non-integrated psychiatric and substance use treatment in this setting appears ineffective.http://www.sajp.org.za/index.php/sajp/article/view/980MethamphetamineSouth AfricaPsychosisPhenomenology |
spellingShingle | Eileen Thomas Helena Lategan Chris Verster Martin Kidd Lize Weich Methamphetamine-induced psychosis: Clinical features, treatment modalities and outcomes South African Journal of Psychiatry Methamphetamine South Africa Psychosis Phenomenology |
title | Methamphetamine-induced psychosis: Clinical features, treatment modalities and outcomes |
title_full | Methamphetamine-induced psychosis: Clinical features, treatment modalities and outcomes |
title_fullStr | Methamphetamine-induced psychosis: Clinical features, treatment modalities and outcomes |
title_full_unstemmed | Methamphetamine-induced psychosis: Clinical features, treatment modalities and outcomes |
title_short | Methamphetamine-induced psychosis: Clinical features, treatment modalities and outcomes |
title_sort | methamphetamine induced psychosis clinical features treatment modalities and outcomes |
topic | Methamphetamine South Africa Psychosis Phenomenology |
url | http://www.sajp.org.za/index.php/sajp/article/view/980 |
work_keys_str_mv | AT eileenthomas methamphetamineinducedpsychosisclinicalfeaturestreatmentmodalitiesandoutcomes AT helenalategan methamphetamineinducedpsychosisclinicalfeaturestreatmentmodalitiesandoutcomes AT chrisverster methamphetamineinducedpsychosisclinicalfeaturestreatmentmodalitiesandoutcomes AT martinkidd methamphetamineinducedpsychosisclinicalfeaturestreatmentmodalitiesandoutcomes AT lizeweich methamphetamineinducedpsychosisclinicalfeaturestreatmentmodalitiesandoutcomes |